Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
5.045
+0.18
(+3.81%)
USD |
NASDAQ |
Oct 26, 16:00
5.14
+0.10
(+1.88%)
After-Hours: 20:00
Shuttle Pharmaceuticals Holdings Total Liabilities (Quarterly) : 3.629M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.629M |
| March 31, 2026 | 8.463M |
| December 31, 2025 | 8.222M |
| September 30, 2025 | 2.149M |
| June 30, 2025 | 1.899M |
| March 31, 2025 | 2.025M |
| December 31, 2024 | 1.797M |
| September 30, 2024 | 1.989M |
| June 30, 2024 | 2.012M |
| March 31, 2024 | 1.992M |
| Date | Value |
|---|---|
| December 31, 2023 | 1.896M |
| September 30, 2023 | 1.766M |
| June 30, 2023 | 1.902M |
| March 31, 2023 | 3.53M |
| December 31, 2022 | 0.9757M |
| September 30, 2022 | 0.9771M |
| June 30, 2022 | 2.480M |
| March 31, 2022 | 2.402M |
| December 31, 2021 | 2.280M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.81M |
| Shareholders Equity (Quarterly) | 19.18M |
| Debt to Equity Ratio | 0.0102 |
| Current Ratio | 0.1139 |
| Net Debt Paydown Yield | 5.59% |